Pain-Relief Effects of Aroma Touch Therapy with Citrus junos Oil Evaluated by Quantitative EEG Occipital Alpha-2 Rhythm Powers

DOI: 10.4236/jbbs.2014.41002   PDF   HTML     4,277 Downloads   6,987 Views   Citations


Aroma touch therapy is widely used in clinical fields for alleviating pain-related symptoms; however, few studies have reported the pain-relief mechanisms. The present study aimed to elucidate the analgesic effects of aroma touch therapy with Citrus junos oil based on the quantitative evaluation of deep brain network (DBN) activity using electroencephalogram (EEG) occipital alpha-2 rhythm (10-13 Hz) powers. Experimental investigations were performed with 13 healthy volunteers using the cold pressor task for simulating chronic pain in three different sessions: a baseline session with no therapies, a control session with a touch therapy, and an aroma touch therapy. We have found for the first time that the interviewed pain ratings represented by Numeric Rating Scale (NRS) scores were strongly correlated with a DBN activity index, which was derived from the slow fluctuation components of occipital EEG alpha-2 rhythm powers. The correlation was characterized by a V-shaped curve in the DBN activity index versus the pain rating, i.e., the NRS score, which provided the complete analgesic states (NRS = 0) for some subjects under aroma touch therapy at an appropriate DBN activity index. Such analgesic states were not so strongly correlated with emotional valence. In conclusion, aroma touch therapy may directly modulate DBN activity so that pain-induced outcomes are minimized.

Share and Cite:

T. Bohgaki, Y. Katagiri and M. Usami, "Pain-Relief Effects of Aroma Touch Therapy with Citrus junos Oil Evaluated by Quantitative EEG Occipital Alpha-2 Rhythm Powers," Journal of Behavioral and Brain Science, Vol. 4 No. 1, 2014, pp. 11-22. doi: 10.4236/jbbs.2014.41002.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] S. R. Adler and J. R. Fosket, “Disclosing Complementary and Alternative Medicine Use in the Medical Encounter: A Qualitative Study in Women with Breast Cancer,” The Journal of Family Practice, Vol. 48, No. 6, 1999, pp. 453-458.
[2] J. Buckle, “Clinical Aromatherapy: Essential Oils in Practice, 2e,” Churchill Livingstone, Livingstone, 2003.
[3] B. R. Cassileth, G. E. Deng, J. E. Gomez, P. A. J. stone, N. Kumarand A. J. Vickers, “American College of Chest Physicians. Complementary Therapies and Integrative Oncology in Lung Cancer: ACCP Evidence Based Clinical Practice Guidelines (2nd Edition),” Chest, Vol. 132, No. 3, 2007, pp. 340-354.
[4] R. Srivastava, “What’s the Alternative? The World Wide Web of Integrative Medicine,” The New England Journal of Medicine, Vol. 366, No. 9, 2012, pp. 783-785.
[5] D. Jimbo, Y. Kimura, M. Taniguchi, M. Inoue and K. Urakami, “Effect of Aromatherapy on Patients with Alzheimer’s Disease,” Psychogeriatrics, Vol. 9, No. 4, 2009, pp. 173-179.
[6] S. Price and L. Price, “Aromatherapy for Health Professionals, 3e,” 4th Edition, Churchill Livingstone, Livingstone, 2011, pp. 61-62.
[7] J. K. Fung, H. W. Tsang and R. C. Chung, “A Systematic Review of the Use of Aromatherapy in Treatment of Behavioral Problems in Dementia,” Geriatrics & Gerontology International, Vol. 12, No. 13, 2012, pp. 372-382.
[8] C. Y. Fu, W. Moyle and M. Cooke, “A Randomised Controlled Trial of the Use of Aromatherapy and Hand Massage to Reduce Disruptive Behaviour in People with Dementia,” BMC Complementary and Alternative Medicine, Vol. 13, 2013, p. 165.
[9] B. Johannessen, “Nurses Experience of Aromatherapy Use with Dementia Patients Experiencing Disturbed Sleep Patterns. An Action Research Project,” Complementary Therapies in Clinical Practice, Vol. 19, No. 4, 2013, pp. 209-213.
[10] D. Sinha and D. Efron, “Complementary and Alternative Medicine Use in Children with Attention Deficit Hyperactivity Disorder,” Journal of Paediatrics and Child Health, Vol. 41, No. 1-2, 2005, pp. 23-26.
[11] N. Morris, S. Birtwistle and M. Toms, “Anxiety Reduction by Aromatherapy: Anxiolytic Effects of Inhalation of Geranium and Rosemary,” International Journal of Aromatherapy, Vol. 7, 1995, pp. 33-39.
[12] P. Conrad and C. Adams, “The Effects of Clinical Aromatherapy for Anxiety and Depression in the High Risk Postpartum Woman: A Pilot Study,” Complementary Therapies in Clinical Practice, Vol. 18, No. 3, 2012, pp. 164-168.
[13] T. Matsumoto, H. Asakura and T. Hayashi, “Does Lavender Aromatherapy Alleviate Premenstrual Emotional Symptoms? A Randomized Crossover Trial,” MedBioPsychoSocial Medicine, Vol. 7, No. 1, 2013, p. 12.
[14] J. Buckle, “Use of Aromatherapy as a Complementary Treatment for Chronic Pain,” Alternative Therapies in Health and Medicine, Vol. 5, No. 5, 1999, pp. 42-51.
[15] M. S. Ju, S. Lee, I. Bae, M. H. Hur, K. Seong and M. S. Lee, “Effects of Aroma Massage on Home Blood Pressure, Ambulatory Blood Pressure, and Sleep Quality in Middle-Aged Women with Hypertension,” Evidence-Based Complementary and Alternative Medicine, 2013, Article ID: 403251.
[16] S. M. Peng, M. Koo andZ. R. Yu, “Effects of Music and Essential Oil Inhalation on Cardiac Autonomic Balance in Healthy Individuals,” Journal of Alternative and Complementary Medicine, Vol. 15, No. 1, 2009, pp. 53-57.
[17] B. Wiegand, K. Luedtke, D. Friscia, M. Nair, M. Aleles and R. McCloskey, “Efficacy of a Comprehensive Program for Reducing Stress in Women: A Prospective, Randomized Trial,” Current Medical Research and Opinion, Vol. 26, No. 4, 2010, pp. 991-1002.
[18] S. Kim, H. J. Kim, J. S. Yeo, S. J. Hong, J. M. Lee and Y. Jeon, “The Effect of Lavender Oil on Stress, Bispectralindex Values, and Needle Insertion Pain in Volunteers,” Journal of Alternative and Complementary Medicine, Vol. 17, No. 9, 2011, pp. 823-826.
[19] S. M. Downer, M. M. Cody, P. McCluskey, P. D. Wilson, S. J. Arnott, T. A. Lister and M. L. Slevin, “Pursuit and Practice of Complementary Therapies by Cancer Patients Receiving Conventional Treatment,” BMJ, Vol. 309, No. 6947, 1994, pp. 86-89.
[20] K. Soden, K. Vincent, S. Craske, C. Lucas and S. Aahley, “A Randomized Controlled Trial of Aromatherapy Massage in a Hospice Setting,” Palliative Medicine, Vol. 18, No. 2, 2004, pp. 87-92.
[21] D. Fellowes, K. Barnes and S. Wilkinson, “Aromatherapy and Massage for Symptom Relief in Patients with Cancer,” Cochrane Database of Systematic Reviews, Vol. 2, 2004, Article ID: CD002287.
[22] D. Boyd, K. Merkh, D. N. Rutledge and V. Randall, “Nurses’ Perceptions and Experiences with End-of-Life Communication and Care,” Oncology Nursing Forum, Vol. 30, No. 3, 2011, pp. 229-239.
[23] K. Boehm, A. Büssing and T. Ostermann, “Aromatherapy as an Adjuvant Treatment in Cancer Care: A Descriptive Systematic Review,” African Journal of Traditional, Complementary and Alternative Medicine, Vol. 9, No. 4, 2012, pp. 503-518.
[24] J. Corner, N. Cawley and S. Hildebrand, “An Evaluation of the Use of Massage and Essential Oils in the Wellbeing of Cancer Patients,” International Journal of Palliative Nursing, Vol. 1, 1995, pp. 67-73.
[25] S. Y. Chang, “Effects of Aroma Hand Massage on Pain, State Anxiety and Depression in Hospice Patients with Terminal Cancer,” Taehan Kanho Hakhoe Chi, Vol. 38, No. 4, 2008, pp. 493-502.
[26] K. Nakano, K. Sato, H. Katayama and M. Miyashita, “Living with Pleasure in Daily Life at the End of Life: Recommended Care Strategy for Cancer Patients from the Perspective of Physicians and Nurses,” Palliat Support Care, 2012, pp. 1-9.
[27] L. Berger, M. Tavares and B. Berger, “A Canadian Experience of Integrating Complementary Therapy in a Hospital Palliative Care Unit,” Journal of Palliative Medicine, Vol. 16, No. 10, 2013, pp. 1294-1298.
[28] S. Beider and C. A. Moyer, “Randomized Controlled Trials of Pediatric Massage: A Review,” Evidence-Based Complementary and Alternative Medicine, Vol. 4, No. 1, 2007, pp. 23-34.
[29] L Corbin, “Safety and Efficiency of Massage Therapy for Patients with Cancer,” Cancer Control, Vol. 12, No. 3, 2005, pp. 158-164.
[30] S. K. Hamid, N. McCann, L. McArdle and A. J. Asbury, “Comparison of Patient-Controlled Sedation with Either Methohexitone or Propofol,” British Journal of Anaesthesia, Vol. 77, No. 6, 1996, pp. 727-730.
[31] S. Wilkinson, J. Aldridge, I. Salmon, E. Cain and B. Wilson, “An Evaluation of Aromatherapy Massage in Palliative Care,” Palliative Medicine, Vol. 13, No. 5, 1999, pp. 409-417.
[32] J. S. Kutner, M. C. Smith, L. Corbin, L. Hemphill, K. Benton, B. K. Mellis, B. Beaty, S. Felton, T. E. Yamashita, L. L. Bryant and D. L. Fairclough, “Massage Therapy versus Simple Touch to Improve Pain and Mood in Patients with Advanced Cancer: A Randomized Trial,” Annals of Internal Medicine, Vol. 149, No. 6, 2008, pp. 369-379.
[33] T. Bohgaki, “Effects of Aroma Touch to a Patient with Multiple-Organ Metastasis after Rectal Cancer Surgery,” The 33rd Academic Conference of JAPAN Academy of Nursing Science, Osaka, 2013, p. 398. (Japanese)
[34] R. Melzack, “Phantom Limbs and the Concept of a Neuromatrix,” Trends in Neurosciences, Vol. 13, No. 3, 1990, pp. 88-92.
[35] D. R. Kenshalo Jr., G. J. Giesler Jr., R. B. Leonard and W. D. Willis, “Responses of Neurons in Primate Ventral Posterior Lateral Nucleus to Noxious Stimuli,” Journal of Neurophysiology, Vol. 43, No. 6, 1980, pp. 1594-1614.
[36] T. Ushida, M. Fukumoto, C. Binti, T. Ikemoto, S. Taniguchi, M. Ikeuchi, M. Nishihara and T. Tani, “Alterations of Contralateral Thalamic Perfusion in Neuropathic Pain,” The Open Neuroimaging Journal, Vol. 4, 2010, pp. 182-186.
[37] V. Di Piero, A. K. Jones, F. Iannotti, M. Powell, D. Perani, G. L. Lenzi and R. S. Frackowiak, “Chronic Pain: A PET Study of the Central Effects of Percutaneous High Cervical Cordotomy,” Pain, Vol. 46, No. 1, 1991, pp. 9-12.
[38] M. J. Iadarola, M. B. Max, K. F. Berman, M. G. ByasSmith, R. C. Coghill, R. H. Gracely and G. J. Bennett, “Unilateral Decrease in Thalamic Activity Observed with Positron Emission Tomography in Patients with Chronic Neuropathic Pain,” Pain, Vol. 63, No. 1, 1995, pp. 55-64.
[39] R. C. Kupers, J. M. Gybels and A. Gjedde, “Positron Emission Tomography Study of a Chronic Pain Patient Successfully Treated with Somatosensory Thalamic Stimulation,” Pain, Vol. 87, No. 3, 2000, pp. 295-302.
[40] U. Ribary, A. A. Ioannides, K. D. Singh, R. Hasson, J. P. Bolton, F. Lado, A. Mogilner and R. Llinas, “Magnetic Field Tomography of Coherent Thalamocortical 40-Hz Oscillations in Humans,” Proceedings of the National Academy of Sciences of United States of America, Vol. 88, No. 24, 1991, pp. 11037-11041.
[41] R. R. Llinás, U. Ribary , D. Jeanmonod, E. Kronberg and P. P. Mitra, “Thalamocortical Dysrhythmia: A Neurological and Neuropsychiatric Syndrome Characterized by Magnetoencephalography,” Proceedings of the National Academy of Sciences of United States of America, Vol. 96, No. 26, 1999, pp. 15222-15227.
[42] J. Stern, D. Jeanmonod and J. Sarnthein, “Persistent EEG Overactivation in the Cortical Pain Matrix of Neurogenic Pain Patients,” Neuroimage, Vol. 31, No. 2, 2006, pp. 721-731.
[43] G. D. Iannetti and A. Mouraux, “From the Neuromatrix to the Pain Matrix (and Back),” Experimental Brain Research, Vol. 205, No. 1, 2010, pp. 1-12.
[44] M. A. Farmer, M. N. Baliki and A. V. Apkarian, “A Dynamic Network Perspective of Chronic Pain,” Neuroscience Letters, Vol. 520, No. 2, 2012, pp. 197-203.
[45] L. Garcia-Larrea and R. Peyron, “Pain Matrices and Neuropathic Pain Matrices: A Review,” Pain, Vol. 154, Suppl. 1, 2013, pp. S29-S43.
[46] S. Kamping, I. C. Bomba, P. Kanske, E. Diesch and H. Flor, “Deficient Modulation of Pain by a Positive Emotional Context in Fibromyalgia Patients,” Pain, Vol. 154, No. 9, 2013, pp. 1846-1855.
[47] J. A. Hashmi, A. T. Baria, M. N. Baliki, L. Huang, T. J. Schnitzer and A. V. Apkarian, “Brain Networks Predicting Placebo Analgesia in a Clinical Trial for Chronic Back Pain,” Pain, Vol. 153, No. 12, 2012, pp. 2393-2402.
[48] Y. Masaoka, M. Takayama, H. Yajima, A. Kawase, N. Takakura and I. Homma, “Analgesia Is Enhanced by Providing Information Regarding Good Outcomes Associated with an Odor: Placebo Effects in Aromatherapy?” Evidence-Based Complementary and Alternative Medicine, Vol. 2013, Article ID: 921802.
[49] L. Colloca, R. Klinger, H. Flor and U. Bingel, “Placebo Analgesia: Psychological and Neurobiological Mechanisms,” Pain, Vol. 154, No. 4, 2013, pp. 511-514.
[50] N. Sadato, S. Nakamura, T. Oohashi, E. Nishina, Y. Fuwamoto, A. Waki and Y. Yonekura, “Neural Networks for Generation and Suppression of Alpha Rhythm: A PET Study,” NeuroReport, Vol. 9, No. 5, 1998, pp. 893-897.
[51] R. I. Goldman, J. M. Stern, J. Engel Jr. and M. S. Cohen, “Simultaneous EEG and fMRI of the Alpha Rhythm,” NeuroReport, Vol. 13, No. 18, 2002, pp. 2487-2492.
[52] M. Schreckenberger, C. Lange-Asschenfeldt, M. Lochmann, K. Mann, T. Siessmeier, H. G. Buchholz, P. Bartenstein and G. Gründer, “The Thalamus as the Generator and Modulator of EEG Alpha Rhythm: A Combined PET/EEG Study with Lorazepam Challenge in Humans,” Neuroimage, Vol. 22, No. 2, 2004, pp. 637-644.
[53] C. L. Larson, R. J. Davidson, H. C. Abercrombie, R. T. Ward, S. M. Schaefer, D. C. Jackson, J. E. Holden and S. B. Perlman, “Relations between PET-Derived Measures of Thalamic Glucose Metabolism and EEG Alpha Power,” Psychophysiology, Vol. 35, No. 2, 1998, pp. 162-169.
[54] K. A. Lindgren, C. L. Larson, S. M. Schaefer, H. C. Abercrombie, R. T. Ward, T. R. Oakes, J. E. Holden, S. B. Perlman, R. M. Benca and R. J. Davidson, “Thalamic Metabolic Rate Predicts EEG Alpha Power in Healthy Control Subjects but not in Depressed Patients,” Biological Psychiatry, Vol. 45, No. 8, 1999, pp. 943-952.
[55] T. Oohashi, E. Nishina, M. Honda, Y. Yonekura, Y. Fuwamoto, N. Kawai, T. Maekawa, S. Nakamura, H. Fukuyama and H. Shibasaki, “Inaudible Highfrequency Sounds Affect Brain Activity: Hypersonic Effect,” Journal of Neurophysiology, Vol. 83, No. 6, 2000, pp. 3548-3558.
[56] K. Omata, T. Hanakawa, M. Morimoto and M. Honda, “Spontaneous Slow Fluctuation of EEG Alpha Rhythm Reflects Activity in Deep-Brain Structures: A Simultaneous EEG-fMRI Study,” PLoS ONE, Vol. 8, No. 6, 2013, Article ID: e66869.
[57] K. A. Birnie, M. Petter, K. E. Boerner, M. Noel and C. T. Chambers, “Contemporary Use of the Cold Pressor Task in Pediatric Pain Research: A Systematic Review of Methods,” The Journal of Pain, Vol. 13, No. 9, 2012, pp. 817-826.
[58] D. Uta, H. Furue, A. E. Pickering, M. H. Rashid, H. Mizuguchi-Takase, T. Katafuchi, K. Imoto and M. Yoshimura, “TRPA1-Expressing Primary Afferents Synapse with a Morphologically Identified Subclass of Substantia-Gelatinosa Neurons in the Adult Rat Spinal Cord,” European Journal of Neuroscience, Vol. 31, No. 11, 2010, pp. 1960-1973.
[59] M. Sawamura, “Essential Oilextraction,” Patent, No. 3842794. (Japan)
[60] M. Nordin, “Low-Threshold Mechanoreceptive and Nociceptive Units with Unmyelinated (C) Fibers in the Human Supraorbital Nerve,” The Journal of Physiology, Vol. 426, 1990, pp. 229-240.
[61] L. S. Loken, J. Wessberg, I. Morrison, F. McGlone and H. Olausson, “Coding of Pleasant Touch by Unmyelinated Afferents in Humans,” Nature Neuroscience, Vol. 12, No. 5, 2009, pp. 547-548.
[62] C. D. Spielberger, R. L. Gorsuch, P. R. Lushene, P. R. Vagg and A. G. Jacobs, “Manual for the State-Trait Anxiety Inventory (Form Y),” Consulting Psychologists Press, Inc., Palo Alto, 1983.
[63] I. Hukunishi, “Global Scale for Depression Manual,” Chiba Test Center, Japan.
[64] T. Hidano, M. Hukuhara and S. Iwawaki, “State-Trait Anxiety Inventory-Form JYZ Manual,” Jitsumukyouikusuppan, 2009. (Japanese)
[65] J. A. Russell and L. F. Barrett, “Core Affect, Prototypical Emotional Episodes, and Other Things Called Successfully Treated with Somatosensory Thalamic Stimulation,” Pain, Vol. 87, No. 3, 2000, pp. 295-302.
[66] S. Anders, M. Lotze, M. Erb, W. Grodd and N. Birbaumer, “Brain Activity Underlying Emotional Valence and Arousal: A Response-Related fMRI Study,” Human Brain Mapping, Vol. 23, No. 4, 2004, pp. 200-209.
[67] A. Williamson and B. Hoggart, “Pain: A Review of Three Commonly Used Pain Rating Scales,” Journal of Clinical Nursing, Vol. 14, No. 7, 2005, pp. 798-804.
[68] C. H. Lee, T. Sugiyama, A. Kataoka, A. Kudo, F. Fujino, Y. W. Chen, Y. Mitsuyama, S. Nomura and T. Yoshioka, “Analysis for Distinctive Activation Patterns of Pain and Itchy in the Human Brain Cortex Measured Using Near Infrared Spectroscopy (NIRS),” PLoS ONE, Vol. 8, No. 10, 2013, Article ID: e75360.
[69] B. Given, C. W. Given, A. Sikorskii, S. Jeon, R. McCorkle, V. Champion and D. Decker, “Establishing Mild, Moderate, and Severe Scores for Cancer Related Symptoms: How Consistent and Clinically Meaningful Are Interference. Based Severity Cutpoints?” Journal of Pain and Symptom Management, Vol. 35, No. 2, 2008, pp. 126-135.

comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.